Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02174445
What this trial is testing

An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years

Who this might be right for
Chronic Myeloid Leukemia
Prof. Dr. Nikolas von Bubnoff 14
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Not applicableStudy completedNCT01860456
What this trial is testing

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

Who this might be right for
Chronic Myeloid Leukemia
University of Pisa 412
Not applicableNot Yet RecruitingNCT07158294
What this trial is testing

Identification of BCR::ABL1 Mutations by Digital PCR in CML

Who this might be right for
Chronic Myeloid Leukemia (CML)
Gruppo Italiano Malattie EMatologiche dell'Adulto 150
Early research (Phase 1)Study completedNCT00964873
What this trial is testing

The HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBlast-phase Chronic Myelogenous Leukemia+3 more
Synta Pharmaceuticals Corp. 29
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT01275196
What this trial is testing

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 267
Early research (Phase 1)Study completedNCT00233961
What this trial is testing

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center 20
Not applicableStudy completedNCT04621851
What this trial is testing

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

Who this might be right for
Chronic Myeloid Leukemia
University of Milano Bicocca 260
Large-scale testing (Phase 3)Study completedNCT00050531
What this trial is testing

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Who this might be right for
Leukemia, Myeloid, Chronic
M.D. Anderson Cancer Center 94
Post-approval studies (Phase 4)Study completedNCT01368523
What this trial is testing

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)UnknownNCT00335868
What this trial is testing

PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center 16
Not applicableStudy completedNCT07151820
What this trial is testing

A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients

Who this might be right for
Leukemia, Chronic Myeloid
Novartis Pharmaceuticals 2,546
Early research (Phase 1)Study completedNCT03018223
What this trial is testing

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Who this might be right for
Non-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more
H. Lee Moffitt Cancer Center and Research Institute 32
Early research (Phase 1)Looking for participantsNCT06994676
What this trial is testing

CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Who this might be right for
High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more
Crossbow Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Early research (Phase 1)WithdrawnNCT04808115
What this trial is testing

IIT PH1 KDS-1001 in Patients With CML

Who this might be right for
CML (Chronic Myelogenous Leukemia
Duke University
Not applicableLooking for participantsNCT05439889
What this trial is testing

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

Who this might be right for
Chronic Myeloid Leukemia, BCR/ABL-Positive
National Taiwan University Hospital 100
Next Page